Vertex Pharmaceuticals
Price & Volume
Stats
See more52W Range | $362.50-$510.77 |
Market Cap | $110.9B |
Shares Short | 4M |
Financials
See moreRevenue (12 Mos) | $12B |
Revenue Growth (YoY) | 9.5% |
Gross Profit (12 Mos) | $6.4B |
Diluted EPS | $15.31 |
News
See moreYahoo Finance • 12 hours ago
Zealand Pharma Appoints Eric Rojas as Vice President and Head of Investor Relations
Yahoo Finance • 4 days ago
Vertex Pharmaceuticals price target raised to $612 from $596 at Morgan Stanley
Yahoo Finance • 6 days ago
Nasdaq, S&P 500, Dow futures slip as hopes of U.S.-Iran resolution fade
About
CEO | Dr. Reshma Kewalramani FASN, M.D. |
CFO | Mr. Charles F. Wagner Jr. |
Address | 50 Northern Avenue, Boston, MA, United States, 02210 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 6,400 |
